Skip to main content Skip to footer

Medicines use review (MUR) / new medicine services (NMS) drug lists

Updated MUR medicines for national target group

From 1 October 2019 to 31 March 2020, at least 70% of MUR service consultations should be done with patients in at least one of the two national target groups:

  • Patients taking a high-risk medicine
  • Patients who’ve been discharged from hospital in the last 8 weeks and had changes made to the drugs they're taking while in hospital

MUR drug list

These products are classified as MUR medicines for patients taking high-risk medicines, as outlined in Part VIC of the drug tariff.

You can view the high-risk medicines:

NMS medicines

As outlined in Part VIC of the drug tariff, you should only do NMS with patients who’ve, for the first time, been prescribed a particular NMS medicine for the following conditions.

You can view each condition and its drug list: